A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes
- 1 February 1991
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 540 (1-2) , 319-321
- https://doi.org/10.1016/0006-8993(91)90528-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- VIP: Molecular biology and neurobiological functionMolecular Neurobiology, 1989
- High-affinity receptors for vasoactive intestinal peptide on human myeloma cells.The Journal of Immunology, 1989
- Vasoactive intestinal peptide receptors in rat spleen and brain: A shared communication networkPeptides, 1988
- A new type of functional VIP receptor has an affinity for helodermin in human SUP‐T1 lymphoblastsFEBS Letters, 1988
- A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29Peptides, 1986
- Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).The Journal of Immunology, 1985
- Interaction of Growth Hormone-Releasing Factor (GRF) and 14 GRF Analogs with Vasoactive Intestinal Peptide (VIP) Receptors of Rat Pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(l-29)-NH2as a VIP Antagonist*Endocrinology, 1985
- In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells.The Journal of Experimental Medicine, 1984
- Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.The Journal of Immunology, 1984